ResearcherKarolinska University HospitalActive in the last 2 years
Joonas H. Kauppila
Matched on ORCID iD 0000-0001-6740-3726; OpenAlex author ID A5023900675. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 5
- Risk of pancreatic cancer after eradication treatment of Helicobacter pylori. Co-author DOI 10.1016/j.ejca.2025.116192↗
- Hospital volume and outcomes of pancreatic cancer: a Finnish population-based nationwide study. Last author DOI 10.1016/j.hpb.2021.10.011↗
- Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000001195↗
- Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12957-018-1432-4↗
- High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients. Co-author DOI 10.1007/s00428-017-2087-1↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Heikki I. Huhta · 4 shared papers, 2017–2022 · strength 0.44
- Paper Hospital volume and outcomes of pancreatic cancer: a Finnish population-based nationwide study. DOI 10.1016/j.hpb.2021.10.011↗
- Paper Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma. DOI 10.1097/mpa.0000000000001195↗
- Paper Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma. DOI 10.1186/s12957-018-1432-4↗
- Jesper Lagergren · 1 shared paper, 2026 · strength 0.30
- Cecilia Radkiewicz · 1 shared paper, 2026 · strength 0.30
- A.-K. Eriksson Wiklund · 1 shared paper, 2026 · strength 0.30
- Joel Isohookana · 3 shared papers, 2017–2019 · strength 0.24
- Paper Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma. DOI 10.1097/mpa.0000000000001195↗
- Paper Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma. DOI 10.1186/s12957-018-1432-4↗
- Paper High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer … DOI 10.1007/s00428-017-2087-1↗
- Joni Leppänen · 3 shared papers, 2017–2019 · strength 0.24
- Paper Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma. DOI 10.1097/mpa.0000000000001195↗
- Paper Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma. DOI 10.1186/s12957-018-1432-4↗
- Paper High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer … DOI 10.1007/s00428-017-2087-1↗
- Tuomo J. Karttunen · 3 shared papers, 2017–2019 · strength 0.24
- Paper Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma. DOI 10.1097/mpa.0000000000001195↗
- Paper Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma. DOI 10.1186/s12957-018-1432-4↗
- Paper High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer … DOI 10.1007/s00428-017-2087-1↗
- Kirsi‐Maria Haapasaari · 3 shared papers, 2017–2019 · strength 0.24
- Paper Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma. DOI 10.1097/mpa.0000000000001195↗
- Paper Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma. DOI 10.1186/s12957-018-1432-4↗
- Paper High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer … DOI 10.1007/s00428-017-2087-1↗
- Peeter Karihtala · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.